Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
The caudate nucleus from examples of Alzheimer's disease (mean age 68, range 51-77 yr) had a mean wet weight and total protein content that were significantly lower than control. Biochemical markers of various specific nerve cells were determined. These are thought to reflect intrinsic choliner...
Váldodahkkit: | Pearce, B, Palmer, A, Bowen, D, Wilcock, G, Esiri, M, Davison, A |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
1984
|
Geahča maid
-
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
Dahkki: Bowen, D, et al.
Almmustuhtton: (1983) -
The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.
Dahkki: Wilcock, G, et al.
Almmustuhtton: (1983) -
Reduced GLP-1R availability in the caudate nucleus with Alzheimer’s disease
Dahkki: Emma Barrett, et al.
Almmustuhtton: (2024-06-01) -
TRPV4 mRNA is elevated in the caudate nucleus with NPH but not in Alzheimer’s disease
Dahkki: Hunter White, et al.
Almmustuhtton: (2022-11-01) -
Interpretive monitoring in the caudate nucleus
Dahkki: Marianna Yanike, et al.
Almmustuhtton: (2014-11-01)